William F. Pool

646 total citations
20 papers, 496 citations indexed

About

William F. Pool is a scholar working on Molecular Biology, Pharmacology and Infectious Diseases. According to data from OpenAlex, William F. Pool has authored 20 papers receiving a total of 496 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 7 papers in Pharmacology and 5 papers in Infectious Diseases. Recurrent topics in William F. Pool's work include Pharmacogenetics and Drug Metabolism (7 papers), HIV/AIDS drug development and treatment (5 papers) and Biochemical and Molecular Research (4 papers). William F. Pool is often cited by papers focused on Pharmacogenetics and Drug Metabolism (7 papers), HIV/AIDS drug development and treatment (5 papers) and Biochemical and Molecular Research (4 papers). William F. Pool collaborates with scholars based in United States and United Kingdom. William F. Pool's co-authors include Thomas F. Woolf, Hai‐Zhi Bu, Ping Kang, Stephen F. Madden, B.Kevin Park, Ellen Y. Wu, Michael D. Reily, Alan Deese, Ping Zhao and Rasmy Talaat and has published in prestigious journals such as Cancer Research, Journal of Medicinal Chemistry and Clinical Chemistry.

In The Last Decade

William F. Pool

20 papers receiving 471 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
William F. Pool United States 12 235 166 123 83 66 20 496
Konstantine W. Skordos United States 9 301 1.3× 168 1.0× 164 1.3× 50 0.6× 38 0.6× 10 501
Faraz Kazmi United States 10 246 1.0× 194 1.2× 156 1.3× 81 1.0× 56 0.8× 17 591
Tsutomu Yoshimura Japan 13 171 0.7× 205 1.2× 183 1.5× 73 0.9× 88 1.3× 28 594
Paul Toren United States 11 284 1.2× 206 1.2× 193 1.6× 96 1.2× 86 1.3× 22 661
Hiroshi Komura Japan 17 286 1.2× 245 1.5× 273 2.2× 82 1.0× 68 1.0× 40 817
H. Noguchi Japan 15 223 0.9× 211 1.3× 196 1.6× 65 0.8× 49 0.7× 58 641
Stella Vincent United States 16 145 0.6× 285 1.7× 182 1.5× 75 0.9× 55 0.8× 35 712
B. Sinués Spain 16 464 2.0× 309 1.9× 238 1.9× 65 0.8× 123 1.9× 35 874
Evan Smith United States 9 255 1.1× 130 0.8× 95 0.8× 61 0.7× 23 0.3× 13 490
Ryan Takahashi United States 13 189 0.8× 173 1.0× 129 1.0× 31 0.4× 58 0.9× 31 443

Countries citing papers authored by William F. Pool

Since Specialization
Citations

This map shows the geographic impact of William F. Pool's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William F. Pool with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William F. Pool more than expected).

Fields of papers citing papers by William F. Pool

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William F. Pool. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William F. Pool. The network helps show where William F. Pool may publish in the future.

Co-authorship network of co-authors of William F. Pool

This figure shows the co-authorship network connecting the top 25 collaborators of William F. Pool. A scholar is included among the top collaborators of William F. Pool based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William F. Pool. William F. Pool is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Smith, Bill J., Yazdi K. Pithavala, Hai‐Zhi Bu, et al.. (2014). Pharmacokinetics, Metabolism, and Excretion of [14C]Axitinib, a Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor, in Humans. Drug Metabolism and Disposition. 42(5). 918–931. 31 indexed citations
2.
Bu, Hai‐Zhi, William F. Pool, Geoffrey W. Peng, et al.. (2011). Pharmacokinetics, Distribution, and Metabolism of [14C]Sunitinib in Rats, Monkeys, and Humans. Drug Metabolism and Disposition. 40(3). 539–555. 85 indexed citations
3.
Bello, Carlo L., Hai‐Zhi Bu, Shem Patyna, et al.. (2007). A phase I mass-balance study to evaluate the metabolism and excretion of [14C]-sunitinib (SU11248) in healthy male subjects. Cancer Research. 67. 6 indexed citations
4.
Bu, Hai‐Zhi, Ping Zhao, Deepak Dalvie, & William F. Pool. (2007). Identification of primary and sequential bioactivation pathways of carbamazepine in human liver microsomes using liquid chromatography/tandem mass spectrometry. Rapid Communications in Mass Spectrometry. 21(20). 3317–3322. 17 indexed citations
5.
Bu, Hai‐Zhi, William F. Pool, Ellen Y. Wu, & Bhasker V. Shetty. (2007). A Unique Example of Drug Metabolism: Tetra- and Penta-Oxygenation Reactions of Capravirine in Rats, Dogs and Humans. Drug Metabolism Letters. 1(1). 61–65. 1 indexed citations
6.
Bu, Hai‐Zhi, Ping Zhao, Ping Kang, et al.. (2007). Evaluation of Capravirine as a CYP3A Probe Substrate: In Vitro and in Vivo Metabolism of Capravirine in Rats and Dogs. Drug Metabolism and Disposition. 35(9). 1593–1602. 2 indexed citations
7.
Bu, Hai‐Zhi, Ping Zhao, Ping Kang, William F. Pool, & Ellen Y. Wu. (2006). Identification of Enzymes Responsible for Primary and Sequential Oxygenation Reactions of Capravirine in Human Liver Microsomes. Drug Metabolism and Disposition. 34(11). 1798–1802. 6 indexed citations
8.
Bu, Hai‐Zhi, Ping Kang, Alan Deese, Ping Zhao, & William F. Pool. (2005). HUMAN IN VITRO GLUTATHIONYL AND PROTEIN ADDUCTS OF CARBAMAZEPINE-10,11-EPOXIDE, A STABLE AND PHARMACOLOGICALLY ACTIVE METABOLITE OF CARBAMAZEPINE. Drug Metabolism and Disposition. 33(12). 1920–1924. 65 indexed citations
9.
Bu, Hai‐Zhi, Ping Kang, Ping Zhao, William F. Pool, & Ellen Y. Wu. (2005). A SIMPLE SEQUENTIAL INCUBATION METHOD FOR DECONVOLUTING THE COMPLICATED SEQUENTIAL METABOLISM OF CAPRAVIRINE IN HUMANS. Drug Metabolism and Disposition. 33(10). 1438–1445. 19 indexed citations
10.
Bu, Hai‐Zhi, William F. Pool, Ellen Y. Wu, et al.. (2004). METABOLISM AND EXCRETION OF CAPRAVIRINE, A NEW NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR, ALONE AND IN COMBINATION WITH RITONAVIR IN HEALTHY VOLUNTEERS. Drug Metabolism and Disposition. 32(7). 689–698. 14 indexed citations
11.
He, Kan, Rasmy Talaat, William F. Pool, et al.. (2004). METABOLIC ACTIVATION OF TROGLITAZONE: IDENTIFICATION OF A REACTIVE METABOLITE AND MECHANISMS INVOLVED. Drug Metabolism and Disposition. 32(6). 639–646. 78 indexed citations
12.
Bao, Donghui, V. Thanabal, & William F. Pool. (2002). Determination of tacrine metabolites in microsomal incubate by high performance liquid chromatography–nuclear magnetic resonance/mass spectrometry with a column trapping system. Journal of Pharmaceutical and Biomedical Analysis. 28(1). 23–30. 8 indexed citations
13.
Annesley, Thomas M, Gerald D. Nordblom, William F. Pool, et al.. (2001). Glucuronidation of Prodrug Reactive Site: Isolation and Characterization of Oxymethylglucuronide Metabolite of Fosphenytoin. Clinical Chemistry. 47(5). 910–918. 8 indexed citations
14.
Pool, William F., Michael D. Reily, Susan M. Bjorge, & Thomas F. Woolf. (1997). Metabolic disposition of the cognition activator tacrine in rats, dogs, and humans. Species comparisons.. PubMed. 25(5). 590–7. 12 indexed citations
15.
Pool, William F., Thomas F. Woolf, Michael D. Reily, et al.. (1996). Identification of a 3-Hydroxylated Tacrine Metabolite in Rat and Man:  Metabolic Profiling Implications and Pharmacology. Journal of Medicinal Chemistry. 39(15). 3014–3018. 12 indexed citations
16.
Park, B. Kevin, et al.. (1994). Tacrine Transaminitis. Alzheimer Disease & Associated Disorders. 8(2). S50–S50. 20 indexed citations
17.
Madden, Stephen F., Thomas F. Woolf, William F. Pool, & B.Kevin Park. (1993). An investigation into the formation of stable, protein-reactive and cytotoxic metabolites from tacrine in vitro. Biochemical Pharmacology. 46(1). 13–20. 88 indexed citations
18.
19.
Teitel, S., Jay O'Brien, William F. Pool, & Arnold Brossi. (1974). Alkaloids in mammalian tissues. 4. Synthesis of (+)- and (-)-salsoline and isosalsoline. Journal of Medicinal Chemistry. 17(1). 134–137. 17 indexed citations
20.
Ning, Robert Y., Leo H. Sternbach, William F. Pool, & Lowell O. Randall. (1973). Quinazolines and 1,4-benzodiazepines. 58. Azido group, a novel pharmacophoric substituent. 7-Azido-5-phenyl-1,4-benzodiazepines. Journal of Medicinal Chemistry. 16(8). 879–882. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Konstantine W. Skordos Breakdown of academic impact, for papers by Faraz Kazmi Breakdown of academic impact, for papers by Tsutomu Yoshimura Breakdown of academic impact, for papers by Paul Toren Breakdown of academic impact, for papers by Hiroshi Komura Breakdown of academic impact, for papers by H. Noguchi Breakdown of academic impact, for papers by Stella Vincent Breakdown of academic impact, for papers by B. Sinués Breakdown of academic impact, for papers by Evan Smith Breakdown of academic impact, for papers by Ryan Takahashi
Rankless by CCL
2026